246 related articles for article (PubMed ID: 24785322)
1. Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
Wernicke AG; Yondorf MZ; Peng L; Trichter S; Nedialkova L; Sabbas A; Kulidzhanov F; Parashar B; Nori D; Clifford Chao KS; Christos P; Kovanlikaya I; Pannullo S; Boockvar JA; Stieg PE; Schwartz TH
J Neurosurg; 2014 Aug; 121(2):338-48. PubMed ID: 24785322
[TBL] [Abstract][Full Text] [Related]
2. Cesium-131 brachytherapy for recurrent brain metastases: durable salvage treatment for previously irradiated metastatic disease.
Wernicke AG; Smith AW; Taube S; Yondorf MZ; Parashar B; Trichter S; Nedialkova L; Sabbas A; Christos P; Ramakrishna R; Pannullo SC; Stieg PE; Schwartz TH
J Neurosurg; 2017 Apr; 126(4):1212-1219. PubMed ID: 27257835
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
Wernicke AG; Hirschfeld CB; Smith AW; Taube S; Yondorf MZ; Parashar B; Nedialkova L; Kulidzhanov F; Trichter S; Sabbas A; Ramakrishna R; Pannullo S; Schwartz TH
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1059-1068. PubMed ID: 28721889
[TBL] [Abstract][Full Text] [Related]
4. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
[TBL] [Abstract][Full Text] [Related]
5. A matched-pair analysis of clinical outcomes after intracavitary cesium-131 brachytherapy versus stereotactic radiosurgery for resected brain metastases.
Julie DA; Lazow SP; Vanderbilt DB; Taube S; Yondorf MZ; Sabbas A; Pannullo S; Schwartz TH; Wernicke AG
J Neurosurg; 2020 May; 134(5):1447-1454. PubMed ID: 32413856
[TBL] [Abstract][Full Text] [Related]
6. Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience.
Dagnew E; Kanski J; McDermott MW; Sneed PK; McPherson C; Breneman JC; Warnick RE
Neurosurg Focus; 2007 Mar; 22(3):E3. PubMed ID: 17608356
[TBL] [Abstract][Full Text] [Related]
7. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
8. Surgical resection and permanent iodine-125 brachytherapy for brain metastases.
Huang K; Sneed PK; Kunwar S; Kragten A; Larson DA; Berger MS; Chan A; Pouliot J; McDermott MW
J Neurooncol; 2009 Jan; 91(1):83-93. PubMed ID: 18719856
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive function and quality of life in patients with newly diagnosed brain metastasis after treatment with intra-operative cesium-131 brachytherapy: a prospective trial.
Pham A; Yondorf MZ; Parashar B; Scheff RJ; Pannullo SC; Ramakrishna R; Stieg PE; Schwartz TH; Wernicke AG
J Neurooncol; 2016 Mar; 127(1):63-71. PubMed ID: 26650067
[TBL] [Abstract][Full Text] [Related]
11. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
12. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
13. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
14. Surgical Technique and Clinically Relevant Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases.
Wernicke AG; Lazow SP; Taube S; Yondorf MZ; Kovanlikaya I; Nori D; Christos P; Boockvar JA; Pannullo S; Stieg PE; Schwartz TH
Oper Neurosurg (Hagerstown); 2016 Mar; 12(1):49-60. PubMed ID: 27774500
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative radiotherapy to treat newly diagnosed solitary brain metastasis: initial experience and long-term outcomes.
Weil RJ; Mavinkurve GG; Chao ST; Vogelbaum MA; Suh JH; Kolar M; Toms SA
J Neurosurg; 2015 Apr; 122(4):825-32. PubMed ID: 25614945
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
17. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.
Jensen CA; Chan MD; McCoy TP; Bourland JD; deGuzman AF; Ellis TL; Ekstrand KE; McMullen KP; Munley MT; Shaw EG; Urbanic JJ; Tatter SB
J Neurosurg; 2011 Jun; 114(6):1585-91. PubMed ID: 21166567
[TBL] [Abstract][Full Text] [Related]
18. Results of a phase II trial of the GliaSite radiation therapy system for the treatment of newly diagnosed, resected single brain metastases.
Rogers LR; Rock JP; Sills AK; Vogelbaum MA; Suh JH; Ellis TL; Stieber VW; Asher AL; Fraser RW; Billingsley JS; Lewis P; Schellingerhout D; Shaw EG;
J Neurosurg; 2006 Sep; 105(3):375-84. PubMed ID: 16961129
[TBL] [Abstract][Full Text] [Related]
19. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
[TBL] [Abstract][Full Text] [Related]
20. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
